Statement from LuMind Research Down Syndrome Foundation on the Roche Clinical Trials

Categories: Blog, Clinical Trials, Ds Research, News
From LuMind RDS Board Chairman, Ryan Hartman We thank you for turning to LuMind Research Down Syndrome with your questions and comments about the news of the Roche CLEMATIS Phase 2 clinical trial for RG1662/Basmisanil. As the largest source of private funding for Down syndrome cognition research, we are in contact with many people from our …

Read More

Response to the Roche Clinical Trial for CLEMATIS

Categories: Blog, Ds Research, News
A response from LuMind Research Down Syndrome President and CEO Carolyn Cronin regarding the end of the Roche Clinical Trial for CLEMATIS. Hello friends, Like you we were disappointed to learn about the end of Roche Clinical Trial for CLEMATIS, the Phase II study investigating the efficacy and safety of basmisanil (RG1662) in adults and …

Read More

Clinical Trial Update: Green Tea’s Effect on Boosting Cognition

Categories: Blog, Clinical Trials, Ds Research, News
News from the phase 2 clinical trial of with a chemical in green tea has been shown to improve cognitive ability in people with Down syndrome, according to researchers from the Centre for Genomic Regulation in Barcelona. The study will be published in The Lancet Neurology, but there are news reports outlining the preliminary results of this interesting …

Read More

Celebrating Down Syndrome Research: Sky’s the Limit

Categories: Blog, Ds Research, Events, News
On May 21, 2016, our Seattle friends as well as friends as far as New York, Illinois, California, and Arizona helped to celebrate the best and brightest in people and organizations responsible for propelling Down syndrome cognition research. We enjoyed a morning of research where 2016 honorees Dr. Michael Rafii and Dr. Roger Reeves joined our …

Read More

Who We Fund: Keeping the Foot on the Pedal

Categories: Blog, Ds Research, News
By Dr. Michael Harpold, LuMind RDS Chief Scientific Officer Dr. Harpold discusses theLuMind RDS research strategy and the importance of nurturing research endeavors through sustained funding. The key objective for the LuMind RDS Research Grants is our mission to stimulate biomedical research that will accelerate the development of safe and effective new therapies to significantly improve cognition, …

Read More